Results 51 to 60 of about 2,148,975 (183)

Peripheral T-Cell Lymphoma of the Submandibular Salivary Gland as an Unusual Manifestation of Richter’s Syndrome: A Case Report and Literature Review

open access: yesCase Reports in Hematology, 2017
Richter’s syndrome is the development of high-grade non-Hodgkin lymphoma (NHL) or Hodgkin lymphoma in patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
Vadim R. Gorodetskiy   +2 more
doaj   +1 more source

Example 2 - NOS - Sound Logo

open access: yes, 2023
NOS Sound Logo from the end of the advertisement "NOS - Downloads a fundo"Original Link: https://www.youtube.com/watch?v=e2sBgwvt0mk16/05 ...
NOS SGPS S.A. (17116910)
core   +1 more source

Mature T‐cell leukemia/lymphoma with an NK‐like immunophenotype: A report of 7 cases

open access: yesCytometry Part B: Clinical Cytometry, EarlyView.
Abstract Distinguishing T‐cell from NK‐cell neoplasms can occasionally be challenging, as neoplastic T cells can lose T‐cell markers such as surface CD3 (sCD3) and CD5 while acquiring NK‐cell markers such as CD16, CD56, and CD94. In this study, we present a series of 7 mature T‐cell lymphoma/leukemia cases with NK‐like immunophenotypes to clarify ...
Wei J. Wang   +8 more
wiley   +1 more source

Detection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR.

open access: yesPLoS ONE, 2014
Angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) are subtypes of T-cell lymphoma. Due to low tumor cell content and substantial reactive cell infiltration, these lymphomas are sometimes mistaken
Rie Nakamoto-Matsubara   +24 more
doaj   +1 more source

Chemotherapy Plus Radiotherapy Versus Chemotherapy Alone for Patients With Peripheral T-Cell Lymphoma, Not Otherwise Specified

open access: yesFrontiers in Oncology, 2021
PurposePeripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) is a clinically and biologically heterogeneous disease with poor prognosis. As the role of radiation therapy (RT) is still unclear, we carried out this study to evaluate the potential ...
Zegeng Chen   +14 more
doaj   +1 more source

Single Atom‐Modified TiO2‐Based Catalysts for Photoelectrochemical Water Splitting: From Fundamentals to Future Prospects

open access: yesENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
Hydrogen and oxygen generated from water splitting process by photoelectrocatalysis of single atom modified TiO2 based photoelectrocatalysts. The accelerating demand for green hydrogen has intensified the development of efficient and durable photoelectrocatalysts (PECs) for sustainable water splitting.
Zichu Zhao   +2 more
wiley   +1 more source

Peripheral T cell lymphoma: Not otherwise specified

open access: yesIndian Journal of Dermatology, 2015
Peripheral T cell lymphoma (PTCL) is a heterogeneous group of hematological tumors originating from mature T cells, which constitutes less than 15% of all non-Hodgkins lymphomas in adults.
Anusha H Pai   +3 more
doaj   +1 more source

Cyclometalated Au(III) Complexes With C*N^N, N^C*N, and C*N Ligands Through C–H Activation

open access: yesZeitschrift für anorganische und allgemeine Chemie, EarlyView.
The complexes [Au(QPhPy)Cl][AuCl4], [Au(QPhCF3Py)Cl][AuCl4], [Au(QPhtBuPy)Cl][AuCl4], [Au(QPhPy)Cl]Cl, [Au(QPyPh)Cl2], [Au(QPyPhCF3)Cl2], [Au(QPyPhtBu)Cl2], [Au(bpyAn)Cl][AuCl4], and [Au(phenAn)Cl][AuCl4] (Q = 8‐quinolinyl, Ph = phenyl, An = anthracen‐9‐yl, Py = pyridyl, bpy = 2,2′′‐bipyridyl, phen = 1,10‐phenanthrolinyl) containing N*C^N, N*C, and NN ...
Pascal L. Jurzick   +5 more
wiley   +1 more source

Impact of primary organ site of involvement by peripheral T‐cell lymphoma not otherwise specified on survival

open access: yesCancer Medicine, 2023
Introduction Peripheral T‐cell lymphoma, not otherwise specified (PTCL‐NOS) is a rare, highly heterogeneous group of mature T‐cell neoplasms that historically has been associated with poor outcomes.
Olivia Davis   +8 more
doaj   +1 more source

Cutaneous T‐cell lymphomas and dupilumab for atopic dermatitis: A systematic review and expert consensus

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Systematic review (51 studies; 547 patients) indicates dupilumab may unmask/worsen CTCL (mainly MF/SS). A French Delphi consensus recommends rigorous diagnostic workup, avoiding dupilumab in confirmed CTCL, discontinuing upon diagnosis, and favouring methotrexate or phototherapy.
Florent Amatore   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy